YOLFTbeta
Neola Medical AB

Neola Medical AB

NEOLA · ST · Healthcare / Medical Devices

0.48SEK-0.02 (-3.23%)

Price History

Full chart

Market Stats

Previous Close0.496
Open0.48
Day Range0.48 – 0.48
52-Week Range0.45 – 2.26
Volume1.00K
Market Cap52.59M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.16
Dividend Yield0.00%
Beta1.44
50-Day Avg0.5375
200-Day Avg0.8268

About

Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMs. Hanna Sjostrom
  • Employees9
  • HeadquartersIdeon Gateway, Lund, Sweden, 223 63, Sweden
  • Websitehttps://www.neolamedical.com

Leadership

  • Ms. Hanna SjostromCEO & MD · b. 1979
  • Mr. David FolkessonChief Financial Officer
  • Ms. Sara BergstenChief Technology Officer · b. 1973
  • Mr. Magnus JohnssonDirector Quality Assurance & Regulatory Affairs · b. 1975

Financials

Income Statement

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue575.00K16.00K31.00K625.00K0000
Growth (%)--97.22%+93.75%+1916.13%-100.00%---
Cost of Revenue1.84M3.18M7.88M7.98M571.00K1.43M1.53M1.39M
Gross Profit-1.27M-3.16M-7.85M-7.36M-571.00K-1.43M-1.53M-1.39M
Gross Margin-220.35%-19762.50%-25329.03%-1176.96%----
Operating Expense00009.82M8.19M9.54M9.75M
Operating Income-1.27M-3.16M-7.85M-7.36M-10.39M-9.62M-11.06M-11.14M
Operating Margin-220.35%-19762.50%-25329.03%-1176.96%----
EBITDA-754.00K-2.60M-6.71M-6.64M-9.82M-7.58M-8.54M-9.75M
EBITDA Margin-131.13%-16243.75%-21645.16%-1062.08%----
Net Income-761.00K-2.61M-6.72M-6.65M-10.35M-9.01M-10.06M-11.02M
Net Income Margin-132.35%-16287.50%-21667.74%-1064.48%----
R&D----200.00K160.00K--
Interest Expense-01.00K0--0189.00K
Interest Expense % of Total Revenue-0.00%3.23%0.00%----

Balance Sheet

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets14.00M12.22M25.97M43.83M75.33M86.02M73.61M78.80M
Total Liabilities671.00K1.50M2.42M3.19M7.84M6.99M4.65M3.00M
Total Equity13.33M10.72M23.55M40.63M67.48M79.03M68.96M75.80M
Cash9.86M5.36M16.64M22.94M40.09M21.58M19.55M16.12M
Net Debt-9.86M-5.36M-16.64M-22.94M-40.09M-21.58M-19.55M-16.12M

Cash Flow

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.32M-2.07M-6.08M-6.93M-8.50M-6.54M-10.84M-11.95M
Investing Cash Flow-1.35M-2.44M-2.17M-10.52M-11.56M-12.30M-11.18M-9.34M
Financing Cash Flow10.00M-19.54M23.74M37.20M336.00K20.00M17.86M
Capital Expenditure1.35M2.44M2.17M10.52M11.56M12.30M11.18M11.95M
Free Cash Flow-2.67M-4.50M-8.25M-17.45M-20.05M-18.85M-10.84M-21.25M
FCF to OCF202.73%217.90%135.80%251.72%236.01%288.09%100.00%177.80%

Earnings

Report DateDec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Dec 29, 2023Dec 31, 2023May 22, 2024Jun 30, 2024Sep 30, 2024Feb 12, 2025May 21, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------
EPS Actual-0.15-0.15-0.20-0.07-0.09-0.10-0.13-0.10-0.07-0.04-0.04-0.04-0.03-0.03-0.04-0.03-0.04-0.04-0.04-0.03-0.03-0.04-0.05
Surprise-----------------------
Timing-----------After-hours-After-hours--Pre-marketPre-market-----

Key Statistics & Ratios

Market Cap52.59M
Enterprise Value47.89M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1383.87
Price / Book0.53
EPS-0.16
Book Value1.25
Revenue (TTM)38.00K
Gross Profit (TTM)-134.00K
EBITDA-11.28M
Profit Margin0.00%
Operating Margin-111.06%
Return on Equity-14.20%
Return on Assets-8.36%
Shares Outstanding110.48M
Shares Float24.02M
Beta1.44
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%